Avails Medical careers
For decades, lab technicians have detected infections through crude, time-consuming, error-ridden techniques of dipsticks and specimen sampling, leaving physicians to guess which antibiotic might be effective since reliable results take days to develop.
Avails Medical has developed digital technology to provide accurate, reproducible, rapid detection of infections in any bodily fluid while indicating real-time which drugs are most effective at the point-of-prescription.
Avails' electronic biosensor technology improves accuracy in detecting infections and provides critical, timely information regarding antibiotic sensitivity and resistance. Avails' cost-effective platform will transform the diagnostics market by enabling diagnostic-guided therapy at the point-of-care for the first time, reducing time-to-treatment from days to minutes.
Avails Medical has developed digital technology to provide accurate, reproducible, rapid detection of infections in any bodily fluid while indicating real-time which drugs are most effective at the point-of-prescription.
Avails' electronic biosensor technology improves accuracy in detecting infections and provides critical, timely information regarding antibiotic sensitivity and resistance. Avails' cost-effective platform will transform the diagnostics market by enabling diagnostic-guided therapy at the point-of-care for the first time, reducing time-to-treatment from days to minutes.
Avails Medical hasn't added any jobs yet
Get notified when Avails Medical posts new jobs.
Naama Stauber Breckler
Founder & CEO @Better Health •
Prev: Founder @CompactCath @MOCACARE @Avails Medical, @StartX alumna, @Stanford MBA, Software Eng & PM
Meike Herget, PhD
Founder & CTO@Avails Medical, Inc. • Studied@Stanford School of Medicine and @Goethe University, Frankfurt, Germany. Expert in Protein Biochemistry.
Oren Knopfmacher
Founder & CEO of Avails Medical, Inc. • Worked at @Novartis • Studied at @Stanford University & Basel • Nanotech (biochemical sensors) - Judo & Crossfit, Opera
Valuation
$0
Funded over
1 round
Latest round
Seed (Sep 2022)
VisiQuate • Santa Rosa • 6 days ago
Bullpen Capital • Enterprise • 2 weeks ago
ClassPass • New York City • $216k – $288k • 2 weeks ago
Pacific Biosciences • Menlo Park • $148k – $222k • 3 weeks ago
Avanquest Software • Canada • 3 weeks ago


